Drugs and Devices

FDA allows marketing of cooling cap for chemotherapy

On Dec. 8, the U.S. Food and Drug Administration (FDA) cleared the Dignitana DigniCap Cooling System for marketing. The system reduces the frequency and severity of alopecia during chemotherapy in breast cancer patients. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares